Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Inozemtsev AN, Bokieva SB, Karpukhina OV, Gumargalieva KZ, Kamensky AA, Myasoedov NF: Semax prevents learning and memory inhibition by heavy metals
Same two caveats apply here as everywhere: compounded products arent FDA-approved finished drugs, and the evidence for 5-Amino-1MQ stays animal-only no matter which of these two dispenses it
GLP-1 agonist FDA-approved once-weekly 0.252.4 mg Dual GIP/GLP-1 agonist FDA-approved once-weekly 2.515 mg Triple agonist (GLP-1/GIP/glucagon) Phase 3 once-weekly 112 mg Dual GLP-1/glucagon agonist Phase 3 once-weekly trial-reported dosing Amylin analog Phase 3 once-weekly 1.24.5 mg HGH fragment preclinical/community daily 300600 mcg NNMT inhibitor preclinical oral 50-150 mg optional SubQ vial math Oral monoamine reuptake inhibitor trial dosing 0.25-0.5 mg daily Tissue Repair & Recovery Peptides Healing-focused compounds studied for tendon, ligament, muscle, and gut tissue repair
Lyophilised Stability 24 months Sealed at -20C, light-protected Reconstituted Stability Up to 3 months Cold-Chain Shipping Always Dry-cold pack, Royal Mail Tracked 24 Important Notice All compounds are sold individually and do not include research supplies
US$ 26.28
US$ 24.25
US$ 24.63
US$ 23.91